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Background: Human Herpesvirus 8 (HHV8), the causative agent of Kaposi’s sarcoma, induces an intense modification
of lipid metabolism and enhances the angiogenic process in endothelial cells. In the present study, neutral lipid (NL)
metabolism and angiogenesis were investigated in HHV8-infected HUVEC cells. The viral replication phases were verified
by rtPCR and also by K8.1 and LANA immunostaining.
Results: Lipid droplets (Nile Red) were higher in all phases and NL staining (LipidTOX) combined with viral-antigen
detection (immunofluorescence) demonstrated a NL content increase in infected cells. In particular, triglyceride synthesis
increases in the lytic phase, whereas cholesteryl ester synthesis rises in the latent one. Moreover, the inhibition of
cholesterol esterification reduces neo-tubule formation mainly in latently infected cells.
Conclusions: We suggest that a reprogramming of cholesteryl ester metabolism is involved in regulating
neo-angiogenesis in HHV8-infected cells and plays a likely role in the high metastatic potential of derived-tumours.
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The Human Herpesvirus 8 (HHV8) is well known for its
peculiar tropism for endothelial cells and B lymphocytes
[1-5]. In fact, it is the causative agent of Kaposi’s sar-
coma (KS) and of several lympho-proliferative diseases,
namely primary effusion lymphoma (PEL) and multi-
centric Castleman’s disease. KS lesions are characterized
by neo-angiogenesis and the production of typical spin-
dle cells of endothelial origin [6,7]. HHV8-infection of
cultured endothelial cells induces profound changes in
the cellular phenotype, which resembles the spindle
shape of KS lesion cells [1]. Moreover, the virus induces
relevant modifications in the behaviour of both primary
and immortalized endothelial cells and causes an intense
transcriptional reprogramming in human umbilical vein
endothelial cells (HUVEC) [8]. It also stimulates the
Warburg effect in latently infected TIME endothelial
cells with an increase of glycolysis and glucose consump-
tion [9] and an activation of hypoxia-induced factors [10].* Correspondence: fangius@unica.it
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unless otherwise stated.HHV8 is believed to establish persistent infection for the
duration of the host’s lifespan, with occasional switching to
the lytic phase of infection [11,12]. In addition, it has been
demonstrated that the HHV8 latency-associated nuclear
antigen (LANA) prolongs the lifespan of primary HUVEC
and enhances cell survival in both serum-deprived condi-
tions and in the presence of apoptotic inducers [13,14].
There are numerous examples in the literature that de-
scribe the biochemical and metabolic alterations in infected
cells [2,3,10,15]. It has recently been found that PEL and
other non-viral lymphoma cells synthesize fatty acids from
glucose at a higher rate and contain more lipid droplets
(LDs) as compared to primary B cells. To sustain the re-
quirements of the proliferating lymphoma cells, the newly
synthesized fatty acids are rapidly stored in triglycerides
(TGs) and/or incorporated into membrane lipids [16].
Other authors have demonstrated that the increase of lipid
synthesis and accumulation in LDs is dependent upon
HHV8-gene expression, even in the latent phase [17].
Cholesteryl esters (CEs) as well as TGs are a common com-
ponent of LDs. They have been found in great numbers in
several diseases, such as tumours, infections [18] and ath-
erosclerosis. However, CE synthesis, their content, andThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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vestigated [19-21]. For this reason, this study focuses on
both CE and TG synthesis and their content during both
lytic and latent HHV8-infection phases. We extended our
investigation to the late latent phase because HHV8-latency
leads to Kaposi’s sarcoma and to other lymphoproliferative
malignancies in humans, characterized by higher CE con-
tent. Furthermore, we also investigated whether the inhib-
ition of CE synthesis could affect neo-angiogenesis, which
represents the main biological property acquired by in-
fected cells, and is responsible for the remarkable meta-
static potential of Kaposi’s sarcoma.
Methods
Cells and viruses
A pool stock of HUVEC cells (Invitrogen, Life Technolo-
gies, UK) was grown in a M200 medium (Gibco, Life
Technologies, UK) with low serum growth supplement
(LSGS, Invitrogen, Life Technologies, UK). HUVEC cells
were always kept in a semi-confluent state and were
sub-cultured at least once a week. Prior to the experi-
ments, the cells had been sub-cultured no more than 3
to 5 times. HHV8 permanently infected BC3 cells were
kindly donated by Dr. Caselli [6] and were grown in a
RPMI-1640 medium supplemented with 10% fetal calf
serum (FCS) (Invitrogen, Life Technologies, UK). BC3
cells were used to produce 100x concentrated stocks of
HHV8, as previously described [22,23]. The virus pellet
was suspended in RPMI, filtered through a 0.22 μm filter
and kept at -80°C until use. The quantitative analysis of
virus genomes present in the stock preparation was ob-
tained by a real-time polymerase chain reaction (qPCR).
The purified cell-free inoculums contained an average
number of 4.7 × 105 copies of viral DNA/ml (data not
shown). For cell infection, about 5.0 × 104/ml HUVEC
cells were seeded in 12 multi-well plates. The cells were
infected with HHV8, concentrated at a multiplicity of at
least 10-20 genomes per cell in a M200 medium
containing 2 μg/ml of polybrene for 2 h at 37°C. After
24-48 h the infected cells were observed with a light
microscope to detect the typical spindle cell morph-
ology. Only cell monolayers with at least 70-80% of
HHV8-infected cells were used for the experiments.
RT-PCR
The presence of HHV8 transcription in HUVEC cells
was analyzed by RT-PCR for the amplification of the
orf26, orf50 and orf73 (LANA) genes. Total RNA was
extracted with a pureLink RNA Mini kit (Life Technolo-
gies, UK) and treated with TURBO DNase (Applied Bio-
systems, UK) before the synthesis of cDNA with a Super
Script VILO kit (Invitrogen, Life Technologies, UK).
RT-PCR amplification was performed using 200 ng of
total RNA extracted from the infected cells as previouslyindicated [23-25]. Primers and conditions for RT-PCR
amplification were as follows: orf26 took place with primers
orf26 fw 5′-GCCGAAAGGATTCCACCATTGTGCT-3′
and orf26 rev 5′- GGGCCCCGGCCGATATTTTGG-3′
for 40 cycles (15'' at 95°C, 1' at 60°C and 15'' at 72°C) plus
10' at 72°C of extension; orf50 amplification took place with
primers orf50 fw 5′-CATGCAGCGGGGTGAGCCTG-3′
and orf50 rev 5′- AGCAGCCCGGCGGTATCGTA-3′ for
40 cycles (15'' at 95°C, 1′ at 60°C and 15′ at 72°C); orf73
amplification took place with primers orf73 fw 5′- AT
CCTCGGGAAATCTGGTCT-3′ and orf73 rev 5′-TT
CAGCGTTTCAGTGTCTGC-3′ for 40 cycles (15'' at
95°C, 1′ at 60°C and 15′ at 72°C) plus 10′ at 72°C of ex-
tension. The amplification of the housekeeping ß-actin
gene (actb) was used as a control with primers actb fw
5′-CACCATTGGCAATGAGCGGTTC-3′ and actb rev
5′- AGGTCTTTGCGGATGTCCACGT-3′ for 40 cycles
(15'' at 95°C, 1′ at 60°C and 15′ at 72°C). RT-PCR
products were run in 2% agarose gels and visualized by
ethidium bromide staining. Acquisition and image pro-
cessing were performed by PhotoDoc-It Imaging System
Digital (UVP, Cambridge, MA) and PhotoPaint expres-
sion (Corel, Ottawa, Canada).Western blot analysis
The cells were lysed at 4°C in a PBS buffer containing
10% SDS, 50 μg TRIS, 1 μM EDTA, pH 7.5, 50 μM DTT
and a protease/phosphatase inhibitor cocktail, homoge-
nized by a UP100H Compact Ultrasonic Laboratory
Device (Hielscher Ultrasonic GmbH, Teltow, Germany).
The protein content of each sample was determined by
the BCA assay (Sigma-Aldrich, Milan, Italy) [26] and
processed as previously described [27]. In particular,
protein samples (12 μg/lane) were separated by electro-
phoresis (acrylamide precast gel; Bio-Rad, Laboratories
Inc., Milan, Italy) and transferred to nitrocellulose,
0.45 μm pore size (Millipore, Milan, Italy) by standard
electro-blotting procedure. The blots were pre-treated
with a blocking solution, ChemiBLOCKER™ (Millipore,
Milan, Italy) diluted 1:3 v/v with TBST (50 μM TRIS-
HCl, pH 7.6, 0.15 M NaCl and 0.05% Tween-20) for at
least 1 h at RT before the addition of the primary
antibodies (dilution 1:200) for K8.1 A/B (mouse mono-
clonal), LN53 (rat monoclonal) and β-actin (goat poly-
clonal). After overnight incubation at 4°C, the primary
antibodies were removed and appropriate horseradish
peroxidase-conjugated secondary antibodies were added
in a dilution range of 1:5000 for at least 1 h at RT. All
the antibodies were purchased from SantaCruz Biotech-
nologies (Dallas, TX, USA). Proteins were detected by
enhanced chemiluminescence (Millipore, Milan, Italy)
and by exposure to X-ray film (Sigma-Aldrich, Milan,
Italy) for various times. Densitometric quantification of
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Viral antigen immunodetection
The cells were processed for microscopy experiments 3,
14 and 24 days after viral infection. In order to carry out
the experiments, both the controls and the HHV8-
infected HUVEC cells were diluted from stock cultures,
seeded (in triplicate) at a density of 2.0 × 105 in 35 mm
glass-bottomed dishes (MatTek, Ashland, MA, USA)
and cultured at 37°C in a 5% CO2 incubator in a growth
medium for 24 h. After fixation with methanol for
10 min, cells were processed for viral immunodetection
using a validated immunofluorescence kit assay (Sci-
medx Corp., Denville, NJ, USA) as indicated by the man-
ufacturer’s instructions. BC3 cells were used as the
positive control.
Immunocytofluorescence and neutral lipid staining
The cells were processed for microscopy experiments 3,
14 and 24 days after viral infection. Two series of experi-
ments were carried out. Both the controls and HHV8-
infected HUVEC cells were diluted from stock cultures
and seeded at a density of 2.0 × 105 in 35 mm glass-
bottomed dishes (MatTek, Ashland, MA, USA) and cul-
tured at 37°C in a 5% CO2 incubator in a growth
medium. After fixation with 4% paraformaldehyde (PFA)
for 10 min, some cell cultures were stained with 300 nM
Nile Red (9-diethylamino-5H-benzo[α]phenoxazine-5-
one; Fluka, Buchs, SG, Switzerland) in PBS [28-30] and
observed, in order to visualize neutral lipids in situ. Nile
Red is a fluorescent dye that differentially stains polar
lipids (i.e. phospholipids) and neutral lipids such as CEs
and TGs. Polar lipids display a red emission, while neu-
tral lipids have a green emission. Red emission was ob-
served with 540 ± 12.5 nm excitation and 590 LP nm
emission filters. Green emission was observed with 460
± 25 nm excitation and 535 ± 20 nm emission filters.
Furthermore, the other series of cell cultures was used
to perform composite staining by firstly using a new
neutral lipid probe called HCS LipidTOX™ Red Neutral
Lipid (Life Technologies Corporation, UK), followed by
an immunocytofluorescence method for identifying K8.1
(mouse monoclonal) or LANA (rat monoclonal) anti-
gens (Santa Cruz Biotechnology, Santa Cruz, CA) with
FITC-conjugated secondary antibodies counterstained in
the same cells with Hoechst 33258 (Sigma-Aldrich,
Milan, Italy) for nuclei. HCS LipidTOX™ Red Neutral
Lipid stain has an extremely high affinity for neutral
lipid droplets and is best imaged with filter sets appro-
priate for Alexa Fluor® 594 dye or Texas Red® dye
(ex577-em609 nm). The XY coordinates were annotated
in order to recognize the same microscopic field. Treble
staining allowed us to evaluate possible differences inneutral lipid content between the control and infected
cells.
Microscopy and imaging
Microscope observations were performed with an Olym-
pus IX71 inverted wide-field fluorescence microscope
(Olympus, Tokyo, Japan) fitted with a 20×/0.7 or 2.5×/
0.075 plan apochromatic objective. Twelve bit-images
were captured using a cooled CCD camera (PCO Sensi-
cam, Kelheim, Germany), electronically coupled to a
mechanical shutter interposed between the 100 W Hg
lamp and the microscope so as to limit photo bleaching.
In some cases the excitation light was attenuated with a
6% neutral density filter. Nominal image resolution was
0.3 and 2.4 μm/pixel for 20 and 2.5× objectives, respect-
ively. Quantitative analysis of images was performed
with the Image Pro Plus package (Media Cybernetics,
Silver Springs, MD, USA). At least 10 microscopic fields
and 200 cells were individually selected and measured
for each experimental group. Calculations were made
with Excel (Microsoft Co., Redmond, WA, USA). Normal-
ized data represent the percentage of the mean density
value (intensity per pixel) ± standard error (SE).
Determination of CE and TG synthesis
HUVEC cells were incubated for 4 h in a medium con-
taining [14C]-oleate bound to bovine serum albumin
(BSA). To prepare the oleate-BSA complex, 3.7 MBq of
[14C]-oleic acid in ethanol (specific activity 2.035 GBq/
mmol) were mixed with 1.4 mg KOH, after which the
ethanol was evaporated. PBS (1.5 ml) without Ca2+ and
Mg2+, containing 4.24 mg BSA (fatty acid-free) was
added and the mixture shaken vigorously. This solution
was added to each well to a final concentration of
74KBq/ml. After incubation, the cells were washed with
ice-cold PBS and lipids extracted with acetone. The cell
lysate was prepared for measuring protein content
(Lowry method). Neutral lipids were separated by thin
layer chromatography (TLC), visualized by iodine va-
pors, and the incorporation of [14C]-oleate into CEs and
TGs was measured in a liquid scintillation counter.
Angiogenic activity assay
The capillary-like micro-tubule formation in both the
control and HHV8-infected cells was performed as re-
ported in the literature [6]. 100 μl of Geltrex matrix
(Gibco, Life technologies, UK) were poured into the bot-
tom of 24 well plates and left to solidify for 1 h at 37°C
as indicated by the manufacturer. After this, 3.0 × 104
cells were seeded in a complete M200 medium and incu-
bated for 24 h in a CO2 incubator at 37°C. In some ex-
periments the cells were incubated in a serum-free
medium. The formation of capillary-like micro-tubules
was checked under a light microscope after 6 and 24 h.
Table 1 SZ inhibits the CE synthesis in HHV8-infected and
control cells
HUVEC HHV8-HUVEC BC3
untreated 100.00 ± 19.51 100.00 ± 12.39 100.00 ± 13.65
SZ *13.16 ± 8.90 *15.19 ± 7.22 *8.42 ± 3.77
Control and HHV8-infected HUVEC and BC3 cells (1.0x106) were treated with
Sandoz 58035 (SZ, 4 μM) for 24 h. Before the last 4 h, [14C]-oleate bound to
BSA was added to the medium and cells were incubated for the remaining
time. Subsequently, cells were washed with ice-cold PBS and lipids extracted
with acetone. Neutral lipids were separated by thin layer chromatography
(TLC), and the incorporation of [14C]-oleate into CEs was determined as described
in Methods. Data were reported as percentage of DPM/106 cells mean ± SE.
Significance was set up when p < 0.05 (*) vs. respective control (t-test).
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literature [13]. In several experiments, the specific
ACAT inhibitor, Sandoz 58035 (SZ; Sigma-Aldrich,
Milan, Italy), was used at a concentration of 4 μM
which, as previously reported for other cell types
[18,27], was the dose that also totally inhibits choles-
terol esterification in HUVEC cells (Table 1) without
altering viability and cell growth. All the samples wereFigure 1 Characterization of lytic and latent phases during long term
HHV8, concentrated at a multiplicity of at least 10-20 genomes per cell in a
Panel A: On days 3, 14 and 24 post infection, 1.0 × 106 cells were harveste
(orf73) viral genes by RT-PCR. HHV8-infected BC3 cells were used as a posit
(for details see Methods). Panel B: At the indicated times (3, 14 and 24 day
required for western blotting (for details see Methods). Panel C: 24 h befor
seeded at a density of 2.0 × 105 in 35 mm glass-bottomed dishes and cult
cells were washed and fixed for the immunofluorescence detection of lytic
The bar in the figure is 30 μm.prepared in triplicate and the experiments were re-
peated at least twice.Statistical analysis
Statistical analysis was performed with GraphPad Prism
(GraphPad Software Inc. La Jolla, CA, USA) software
and Statistica (StatSoft, Tulsa, OK, USA). All data were
expressed as the mean ± SE of experiments in triplicate
and analyzed by the t-student test or ANOVA, and LSD-
Fisher as a post-hoc test when required. Data were con-
sidered significant when p < 0.05.Results
Characterization of lytic and latent phases during long
term HHV8 infection of HUVEC cells
HHV8-infected cells were in good shape and continued
to replicate for up to 6-8 weeks after infection, whereas
control cells started to slow their growth and show signs
of senescence after 4 weeks of culture. For this reason,HHV8 infection of HUVEC cells. HUVEC cells were infected with
M200 medium containing 2 μg/ml of polybrene for 2 h at 37°C.
d and RNA-extracted for detection of lytic (orf26 and orf50) and latent
ive control. The housekeeping β-actin gene was used as a control
s post infection) sub-confluent cells were harvested and processed as
e the indicated times (3, 14 and 24 days post infection), cells were
ured at 37°C in a 5% CO2 incubator in a growth medium. Thereafter,
(K8.1) and latent (LANA) viral-antigens (green) as reported in Methods.
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infection (Figure 1). On days 3 and 14, lytic genes orf26
and orf50 were both clearly expressed, whilst latent gene
orf73, slightly expressed on day 14, was the only gene
transcribed on day 24. Gene expression data were con-
firmed by western blotting analysis (Figure 1B) and im-
munofluorescence detection for lytic (K8.1) and latent
(LANA) viral-antigens (Figure 1C). Indeed, on day 3 at
least 70-80% of cells were K8.1-positive; on day 14 a
mixed population of either K8.1- or LANA-positive cells
was present, whereas on day 24 about 40-60% of cells
were LANA-positive.
Neutral lipid accumulation in lipid droplets in HHV8-infected
HUVEC cells
Figure 2A shows a remarkable increase of neutral lipids
in LDs in all the HHV8-infected cells when compared to
the respective control. As demonstrated by imaging
analysis, the highest increase was observed on day 3
(Figure 2B). As is evident from the images, there is a
heterogeneous distribution of LDs throughout the cells,
probably due to the mixed population of infected/unin-
fected cells. In order to ascertain whether the neutralFigure 2 Neutral lipid content in lipid droplets in HHV8-infected HUV
Figure 1. 24 h before the indicated times, cells were seeded at a density of
5% CO2 incubator in a growth medium. On days 3, 14 and 24 post infectio
reported as green/yellow dots in the figure (panel A). The bar in the figure
green fluorescence intensity. At least 200 cells were individually selected an
the percentage of the mean density value (intensity per pixel) ± standard e
respective control (ANOVA and Fischer’s LSD as post hoc test).lipid increase was a peculiarity of the infected cells, we
next used a double stain for neutral lipids (LipidTOX,
red) combined with FITC-conjugated antibodies (green)
for the detection of viral-antigens, namely K8.1 on day 3
and LANA on days 14 and 24 (Figure 3A). Imaging ana-
lysis of the merged images demonstrated that LDs were
definitely higher in infected-cells (Figure 3B). In particu-
lar, when the LDs were only evaluated in infected cells,
the strong increase of LDs was more evident on day 14
(p < 0.001). The differences between the infected and
control cells were statistically significant (p < 0.05).
Synthesis of TGs and CEs in HHV8 infected HUVEC cells
Neutral lipids stored in LDs are variably constituted by
TGs and CEs. To evaluate their major component in
infected cells, we measured TG and CE synthesis at
the different phases of infection. As demonstrated in
Figure 4A, on days 3 and 14, TG synthesis was higher
than the respective control, but significant only on day 3
(p < 0.05), whereas on day 24, TG synthesis significantly
decreased (p < 0.01). However, CE synthesis did not
change on days 3 and 14, whereas, on day 24 when all
the infected cells were in a latent state, CE synthesis wasEC cells. HUVEC cells were infected with HHV8 as described in
2.0 × 105 in 35 mm glass-bottomed dishes and cultured at 37°C in a
n, cells were fixed and stained with Nile Red (for details see Methods),
is 30 μm. Panel B represents the quantitative analysis of Nile Red
d analyzed for each experimental group. Normalized data represent
rror (SE). Significance was set up when p < 0.05 (*) or p < 0.01(**) vs.
Figure 3 (See legend on next page.)
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Figure 3 Neutral lipid detection and quantification in HHV8-infected HUVEC cells by LipidTOX dye. HUVEC cells were infected with
HHV8 as described in Figure 1. 24 h before the indicated times, cells were seeded at a density of 2.0 × 105 in 35 mm glass-bottomed dishes and
cultured at 37°C in a 5% CO2 incubator in a growth medium. On days 3, 14 and 24 post infection, cells were fixed and treble-stained with firstly
HCS LipidTOX™ Red Neutral Lipid stain (red), followed by an immunocytofluorescence method for identifying lytic (K8.1) and latent (LANA)
viral-antigens with FITC-conjugated secondary antibodies (green) in the same cells counterstained with Hoechst 33258 for nuclei (blue), for details
see Methods (panel A). The bar in the figure is 30 μm. Panel B represents the quantitative analysis of HCS LipidTOX™ Red Neutral Lipid stain
fluorescence intensity. This method allowed the quantification of the neutral lipids in LDs in HHV8-infected cells alone. At least 10 microscopic
fields were individually analysed for each experimental group. Normalized data represent the percentage of the mean density value (intensity per
pixel) ± SE. Significance was set up when p < 0.05 (*) or p < 0.001 (***) vs. respective control (ANOVA and Fischer’s LSD as post hoc test).
Angius et al. BMC Microbiology  (2015) 15:74 Page 7 of 10about 69% higher than the respective control (Figure 4B,
p < 0.001).CE synthesis inhibition induces impairment of HUVEC cell
neo-angiogenic activity
In order to verify whether neutral lipids, specifically CEs,
could somehow also be involved in the peculiar modifi-
cations induced by lytic or latent HHV8 infection, we
evaluated their possible role in neo-angiogenesis, which
is typically enhanced in HHV8-infected cells. In fact, the
neo-angiogenic properties of HHV8 are necessary for
the formation of the characteristic lesions of Kaposi’s
angiosarcoma [1-6]. In the angiogenic activity assay,
both control and lytic (day 3) or latent (day 24) HHV8-
infected cells produced micro-tubules within 24 h
(Figure 5A and B). The specific inhibitor of CE synthesis
SZ 58035 significantly reduced tubule formation in in-
fected cells on day 24 (p < 0.001) but not during the lytic
infection (day 3). Interestingly, control cells grown in a
serum-free M200 medium were not able to produce
complete capillary micro-tubules, whilst HHV8-infected
cells still formed regular and almost normal tubules (p <
0.05). Furthermore, in these conditions (Figure 5A and B)
SZ was also able to dramatically reduce tubule formation
(p < 0.001) in both lytic and latent infection, as confirmed
by evaluation of the angiogenic index (Figure 5B) [13].Figure 4 TG and CE synthesis in HHV8-infected and control HUVEC ce
On days 3, 14 and 24 post infection, 1.0 × 106 cells were incubated for 4 h
(BSA). Subsequently, cells were washed with ice-cold PBS and lipids extracted w
(TLC), and the incorporation of [14C]-oleate into TGs (panel A) and CEs (panel B
± SE. Significance was set up when p< 0.05 (*) vs. respective control (t-test).Discussion
HHV8 is known for its endothelial tropism and is gener-
ally related to proliferative diseases, mainly KS. Recently,
dysfunctional glucose metabolism in vitro [23], and a
high prevalence of HHV8 infection in subjects with dia-
betes mellitus [24] have been reported. Neutral lipid in-
crease in LDs, mainly TGs, has been reported in several
herpes virus infections, and considered an effect of the
reprogramming induced by the viral infection to consent
virion production [31]. A few reports have described the
presence of HHV8 in plaque lesions, but the possible
correlation with atherosclerosis has yet to be clarified
[32,33]. In the present study, we investigated neutral
lipid metabolism and LD content during the lytic and la-
tent phases of endothelial HHV8-infection. In fact, most
studies have investigated the effect of cell reprogram-
ming on lipids in the first days of infection. We present
a model that allows the HHV8-infectious effect on cell
metabolism to be investigated from the lytic to the late
latent phase for up to more than three weeks, which is
particularly suitable for HHV8-infection of endothelial
cells. Even though, as shown by immunofluorescence,
40-60% of cells still appeared to be infected on day 24
after infection, it was not possible to prolong the experi-
ment any further because the cells gradually lost their viral
episome and rapidly started to show some signs of senes-
cence (data not shown). TG synthesis was increased in thells. HUVEC cells were infected with HHV8 as described in Figure 1.
in a medium containing [14C]-oleate bound to bovine serum albumin
ith acetone. Neutral lipids were separated by thin layer chromatography
) was determined as described in Methods. Data were reported as mean
Figure 5 (See legend on next page.)
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Figure 5 Capillary-like vascular micro-tubule formation in HHV8-infected and control HUVEC cells. HUVEC cells were infected with HHV8
as described in Figure 1. 24 h before the indicated times, 3.0 × 104 cells were seeded in plates previously coated with Geltrex matrix and cultured
in a complete or serum-free M200 medium in a CO2 incubator at 37°C. The specific ACAT inhibitor Sandoz 58035 (SZ, 4 μM) was added in some
experimental groups. Capillary-like microtubule formation in the control and HHV8-infected HUVEC cells was performed as described in the
Methods section. Panel A shows the light microscope images of micro-tubule formation in control, lytic and latent HHV8-infected HUVEC cells
cultured in medium with or without (W/O) fetal calf serum (FCS). The bar in the figure is 240 μm. Panel B represents the angiogenic index
quantification (for details, see Methods). All the samples were prepared in triplicate and the experiments were repeated at least twice. Data were
reported as mean ± SE. Significance was set up when p < 0.05 (*) or p < 0.001 (***) vs. respective control (t-test).
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not significantly modified for up to 14 days suggests
that the higher LD content was due to TG content.
Conversely, TG synthesis was lower, whereas choles-
terol esterification underwent a remarkable increase in
the latent phase, suggesting that, while TGs are prom-
inent in the lytic phase, CEs are the prominent neutral
lipid fraction in the late latent phase. It is worth
noting that we performed our lipid synthesis analysis
in a mixed population of infected/uninfected cells, as
demonstrated by immunofluorescence. Based on this
consideration, it is likely that our results could
be underestimated. To overcome this problem, we
double-stained neutral lipids (LipidTOX) and viral-
antigens (immunofluorescence) in the same cells, and
the results confirmed that neutral lipids increased only
in infected cells. An increase of TG-enriched LDs dur-
ing the lytic phase of viral infection has often been re-
ported for HCV virus. In fact, it has been suggested
that the virus uses TG-enriched LDs as a platform for
the assembly of nascent virions, and that the HCV
core protein is a main player in the manipulation of
these organelles [34,35]. Overall, these observations
highlight that a range of viruses (HBV, GBV-B,
Dengue virus) have evolved mechanisms to interact
with LDs and possibly to subvert the function of these
organelles, so as to use them as a platform for viral
particle assembly [31]. Accordingly, our results sup-
port the fact that TG synthesis and LD increase are
mainly necessary during active virus replication. On
the contrary, in the latent phase of HHV8-infection,
LD content seems to be mainly constituted by CEs, as
suggested by the high rate of cholesterol esterification.
High CE content and cholesterol esterification in-
crease are frequently reported in cancer cells and tu-
mours [18,27]. The storage of CEs has been related to
the large amount of cholesterol needed by malignant
cells to sustain membrane biogenesis. Although the
real significance of CEs in cancer cells is far from
being clarified, CEs have recently been related to the
aggressiveness and metastatic properties of prostate
cancer [36,37]. For the first time, we observed the
increase of cholesterol esterification in the latent
phase, which can be considered equivalent to persistentinfection in humans, and as leading to KS. The most
common pathogenic effect expressed by HHV8 in KS
is represented by the angiogenic activity of infected
cells. Accordingly, angiogenesis is one of the major
effects produced by HHV8-chronic infection in vitro
and, just as in cancer cells, still present even in serum-
deprived conditions [13]. For these reasons, we inhib-
ited CE formation using a specific ACAT inhibitor
(Sandoz 58035), which is able to inhibit cholesterol
esterification up to 90%, but does not affect TG synthe-
sis. In contrast with the control, HHV8-infected cells
produced micro-tubules even in serum-deprived con-
ditions. Interestingly, the inhibition of CE formation
was accompanied by a remarkable reduction of micro-
tubules in HHV8-infected cells.Conclusions
HHV8-infection induces an enhancement of neutral
lipid synthesis and the accumulation of LDs in HUVEC
cells. The TG increase in the lytic phase is probably re-
lated to peculiar metabolic viral requirements. On the
other hand, CEs seem to be closely related to the angio-
genic properties of the infected cells, mainly in the latent
phase of infection, suggesting that these neutral lipids
may, in some way, be functionally involved in regulating
the malignant process. These findings suggest that the
use of cholesterol esterification inhibitors on HHV8-
derived tumours could be a useful therapeutic tool in
KS. In fact, angiogenesis inhibition may help to prevent
the occurrence of the diffusion of angiosarcoma and
metastasis.
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